IFI16 and Insulin resistance: In conclusion, our data show that IFI202b and its human orthologue IFI16 are key players in the development of obesity and insulin resistance: (1) by modulating fat storage in adipose tissue and liver; (2) by inhibiting beiging of WAT; and (3) by inducing inflammatory markers.